A. Martin

发表

A refined molecular taxonomy of breast cancer

F. Bertucci, D. Birnbaum, P. Finetti, 2011, Oncogene.

Patterns of relapse in poor-prognosis germ-cell tumours in the GETUG 13 trial: Implications for assessment of brain metastases.

S. Culine, C. Logothetis, G. Le Teuff, 2017, European journal of cancer.

Identification of a basal-like subtype and comparative effect of epirubicin-based chemotherapy and sequential epirubicin followed by docetaxel chemotherapy in the PACS 01 breast cancer trial: 33 markers studied on tissue-microarrays (TMA).

F. Penault-Llorca, E. Charafe-Jauffret, S. Marque, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

1140PDPredictive biomarkers for hyper-progression (HP) in response to immune checkpoint inhibitors (ICI) – analysis of somatic alterations (SAs)

Siraj M. Ali, D. Kilari, P. Ritch, 2017 .